| Titolo |
Pubblicato in |
Anno |
| 2024 consensus document of the Italian Society of Arterial Hypertension (SIIA) and the Italian Society of Cardiovascular Prevention (SIPREC): update on LDL cholesterol lowering in patients with arterial hypertension |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2025 |
| Aortic Remodeling in Patients with Arterial Hypertension: Pathophysiological Mechanisms, Therapeutic Interventions and Preventive Strategies-A Position Paper from the Heart and Hypertension Working Group of the Italian Society of Hypertension |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2025 |
| Prognostic Value and Relative Cutoffs of Triglycerides Predicting Cardiovascular Outcome in a Large Regional-Based Italian Database |
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE |
2024 |
| Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2024 |
| Triglyceride-glucose Index and Mortality in a Large Regional-based Italian Database (Urrah Project) |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
2024 |
| Giant coronary aneurysm and acute myocardial infarction: clinical case report and literature review |
CLINICAL RESEARCH IN CARDIOLOGY |
2024 |
| Serum Uric Acid/Serum Creatinine Ratio and Cardiovascular Mortality in Diabetic Individuals-The Uric Acid Right for Heart Health (URRAH) Project |
METABOLITES |
2024 |
| Systematic Review Article: New Drug Strategies for Treating Resistant Hypertension-the Importance of a Mechanistic, Personalized Approach |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
| A Mobile App-based Approach in Cardiovascular Disease Prevention: A Prospective Randomized Study |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
| May Measure Month 2022 in Italy: A Focus on Fixed-dose Combination, Therapeutic Adherence, and Medical Inertia in a Nationwide Survey |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
| Prevalence, clustering, and current management of cardiovascular risk factors upon first referral to hypertension specialists: the APPROACH study |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
| Gut Microbiota Dysbiosis and Sleep Disorders: Culprit in Cardiovascular Diseases |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Commentary on Paper Entitled "The Effects of Ketogenic Diet on Systolic and Diastolic Blood Pressure: A Systematic Review and Meta-regression Analysis of Randomized Controlled Trials" |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
| Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2024 |
| Serum Uric Acid, Hypertriglyceridemia, and Carotid Plaques: A Sub-Analysis of the URic Acid Right for Heart Health (URRAH) Study |
METABOLITES |
2024 |
| Effect of Coenzyme Q10 on Physical Performance in Older Adults with Statin-Associated Asthenia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial |
JOURNAL OF CLINICAL MEDICINE |
2024 |
| Risk of Cardiovascular Events in Metabolically Healthy Overweight or Obese Adults: Role of LDL-Cholesterol in the Stratification of Risk |
DIAGNOSTICS |
2024 |
| Cardiomyopathy and Sudden Cardiac Death: Bridging Clinical Practice with Cutting-Edge Research |
BIOMEDICINES |
2024 |
| Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases |
JOURNAL OF HYPERTENSION |
2024 |
| Position statement of the Italian Society of Cardiovascular Prevention (SIPREC) and Italian Heart Failure Association (ITAHFA) on cardiac rehabilitation and protection programs as a cornerstone of secondary prevention after myocardial infarction or revascularization |
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION |
2024 |
